Report #2838899

Received Apr 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (NO BRAND NAME)	UNKNOWN MANUFACTURER	2	UNK	—

Symptoms (1)

Hypersomnia

Symptom narrative

slept a lot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sleep excessive in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sleep excessive (Verbatim: slept a lot). The outcome of the sleep excessive was resolved. It was unknown if the reporter considered the sleep excessive to be related to Shingles vaccine. It was unknown if the company considered the sleep excessive to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 24-APR-2025 This case was reported by a patient via interactive digital media. The patient had both shots and first had no problem and after the second slept a lot and patient was good.